Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Recommendations for respiratory syncytial virus surveillance at the national level

Research output: Contribution to journalJournal articleResearchpeer-review

  1. 3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk Factors for Being Seronegative following SARS-CoV-2 Infection in a Large Cohort of Health Care Workers in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact analysis of rotavirus vaccination in various geographic regions in Western Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Anne C Teirlinck
  • Eeva K Broberg
  • Are Stuwitz Berg
  • Harry Campbell
  • Rachel M Reeves
  • AnnaSara Carnahan
  • Bruno Lina
  • Gatis Pakarna
  • Håkon Bøås
  • Hanna Nohynek
  • Hanne-Dorthe Emborg
  • Harish Nair
  • Janine Reiche
  • Jesus Angel Oliva
  • Joanne O Gorman
  • John Paget
  • Karol Szymanski
  • Kostas Danis
  • Maja Socan
  • Manuel Gijon
  • Marie Rapp
  • Martina Havlíčková
  • Ramona Trebbien
  • Raquel Guiomar
  • Siddhivinayak S Hirve
  • Silke Buda
  • Sylvie van der Werf
  • Adam Meijer
  • Thea K Fischer
View graph of relations

Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections and hospitalisations among young children and is globally responsible for many deaths in young children, especially in infants aged <6 months. Furthermore, RSV is a common cause of severe respiratory disease and hospitalisation among older adults. The development of new candidate vaccines and monoclonal antibodies highlights the need for reliable surveillance of RSV. In the European Union (EU), no up-to-date general recommendations on RSV surveillance are currently available. Based on outcomes of a workshop with 29 European experts in the field of RSV virology, epidemiology and public health, we provide recommendations for developing a feasible and sustainable national surveillance strategy for RSV that will enable harmonisation and data comparison at the European level. We discuss three surveillance components: active sentinel community surveillance, active sentinel hospital surveillance and passive laboratory surveillance, using the EU acute respiratory infection and World Health Organization (WHO) extended severe acute respiratory infection case definitions. Furthermore, we recommend the use of quantitative reverse transcriptase PCR-based assays as the standard detection method for RSV and virus genetic characterisation, if possible, to monitor genetic evolution. These guidelines provide a basis for good quality, feasible and affordable surveillance of RSV. Harmonisation of surveillance standards at the European and global level will contribute to the wider availability of national level RSV surveillance data for regional and global analysis, and for estimation of RSV burden and the impact of future immunisation programmes.

Original languageEnglish
Article number2003766
JournalThe European respiratory journal
Volume58
Issue number3
ISSN0903-1936
DOIs
Publication statusPublished - Sep 2021

ID: 65157421